She added, “We filed this lawsuit to stop Vyera’s egregious conduct, make the company pay for its illegal scheming, and block Martin Shkreli from ever working in the pharmaceutical industry again. We won’t allow ‘Pharma Bros’ to manipulate the market and line their pockets at the expense of vulnerable patients and the health care system.”
On the other hand, FTC’s Bureau of Competition Director, Gail Levine, said, “Daraprim is a lifesaving drug for vulnerable patients. Vyera kept the price of Daraprim astronomically high by illegally boxing out the competition.”
